FilingReader Intelligence
Buchang Pharma cuts subsidiary stake, signs Philippines deal
August 7, 2025 at 05:10 PM UTC•By FilingReader AI
Shandong Buchang Pharmaceuticals is reducing its stake in subsidiary Jinan Buchang Caigan Commercial from 93% to 90%, with some transfers at nil consideration.
Separately, subsidiary Luzhou Buchang signed an exclusive supply agreement with Goodfellow Pharma Corporation for Efparepoetin alfa in the Philippines.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SSE:603858•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Shandong Buchang Pharmaceuticals publishes news
Free account required • Unsubscribe anytime